About Acidron 4 mg/5 ml IV Infusion
Acidron is a brand of zoledronic acid, a bisphosphonate medicine given as an intravenous infusion. It is used to treat high blood calcium caused by cancer and certain bone problems, and it works by slowing bone breakdown.
There are 2 brands of Zoledronic Acid [For hypercalcemia] listed in Bangladesh. By unit price, Acidron is among the cheapest of them.
What is Acidron 4 mg/5 ml IV Infusion?
Acidron IV Infusion is a bisphosphonate preparation with the generic name zoledronic acid, intended for hypercalcemia. It is given by intravenous infusion and works mainly on bone by reducing the activity of cells that break down bone. It is used in the management of raised blood calcium associated with cancer and in some bone conditions related to tumours. Because it is a hospital-administered medicine, the doctor decides whether it is suitable and how it should be given. Patients should tell the doctor about kidney problems, pregnancy, breastfeeding and all other medicines they take.
Uses of Acidron
Acidron is used to treat hypercalcemia of malignancy, which is a high level of calcium in the blood caused by cancer. It is also used for bone metastases from solid tumours, osteolytic lesions in multiple myeloma, and several bone conditions including osteoporosis and Paget's disease of bone. It belongs to the bisphosphonate group of medicines. The doctor decides whether it is appropriate for a particular patient.
How to use Acidron
Acidron is given as an intravenous infusion by a healthcare professional, usually in a clinic or hospital. The doctor decides the dose and course. Patients are usually asked to drink fluids before and after the infusion to stay hydrated. Blood tests for calcium, phosphate, magnesium, potassium and kidney function may be checked during treatment. Do not attempt to use this medicine at home. Ask the doctor or pharmacist about anything you do not understand.
Side effects of Acidron
Common side effects after a dose can include headache, nausea, vomiting, constipation, loss of appetite, tiredness, fever, flu-like symptoms, bone pain, muscle pain and joint pain. Some people may have low calcium or low phosphate levels in the blood. Serious problems can include jaw bone damage and kidney problems. Tell your doctor promptly about jaw pain, tooth problems, fever, or any unusual symptoms after treatment.
Safety and precautions
Acidron is not for people with severe kidney problems, low blood calcium or an allergy to bisphosphonates. It is contraindicated in pregnancy and breastfeeding, and it is not recommended for children and adolescents. Good hydration is important before and after the infusion. The doctor will monitor kidney function and blood mineral levels. Tell your doctor if you have kidney disease, take diuretics or aminoglycosides, or have dental problems. Ask the doctor first if you are pregnant, planning pregnancy or breastfeeding.
Frequently asked questions
What is the price of Acidron?
The listed price is ৳ 5000.00.
What does the generic name zoledronic acid mean?
Zoledronic acid is the active ingredient in Acidron. It belongs to a group of medicines called bisphosphonates. These medicines work on bone by slowing down the cells that break down bone tissue.
What is Acidron used for and what kind of medicine is it?
Acidron is a bisphosphonate used to treat high blood calcium caused by cancer and certain bone problems such as bone metastases and Paget's disease. It is given as an intravenous infusion by a healthcare professional.
What do the dosage form and strength mean?
Acidron comes as an intravenous infusion, which means it is given into a vein by a healthcare professional. The strength shown on the pack is 4 mg/5 ml. Your doctor decides the dose and course that are right for you.
- Strength
- 4 mg/5 ml
Price in Bangladesh
৳ 4900 ৳ 5000.00 2% off unit price
Price updated: 18 Nov 2026
Indications
Acidron is indicated in:
- Hypercalcaemia of malignancy,
- Bone metastases associated with solid tumours, Osteolytic lesions associated with multiple myeloma,
- Corticosteroid-induced osteoporosis, Increase bone mass in men with osteoporosis, Osteoporosis in postmenopausal women
- Paget's disease of bone
- Prophylaxis of postmenopausal osteoporosis
Pharmacology
Zoledronic acid belongs to the class of nitrogen-containing bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclast-mediated bone resorption. The action of bisphosphonates on bone is based on their high affinity for mineralized bone. Intravenously administered Zoledronic acid is rapidly distributed to bone. The main molecular target of Zoledronic acid in the osteoclast is the enzyme farnesyl pyrophosphate synthase, but this does not exclude other mechanisms. Clinical studies in tumour-induced hypercalcemia demonstrated that the effect of Zoledronic acid is characterized by decreases in serum calcium and urinary calcium excretion. In addition to its inhibitory activity against bone resorption, Zoledronic acid also possesses anti-tumour activity, anti-angiogenic activity, anti-pain activity, cytostatic and pro-apoptotic activity on tumour cells and synergistic cytostatic effect with other anti-cancer drugs. There was no accumulation of the active substance in plasma after multiple doses given every 28 days. Zoledronic acid is not metabolized and is excreted unchanged via the kidney.
Dosage & Administration
Hypercalcemia of malignancy: The maximum recommended dose of Zoledronic Acid in hypercalcemia of malignancy (serum calcium 12 mg/dl or 3.0 mmol/l) is 4 mg. The 4 mg dose must be given as a single-dose intravenous infusion. Dose adjustment of Zoledronic Acid is not necessary in treating patients for hypercalcemia of malignancy presenting with mild-to-moderate renal impairment. Re-treatment with Zoledronic Acid may be considered if serum calcium does not return to normal after initial treatment. It is recommended that a minimum of 7 days elapse before re-treatment, to allow for full response to the initial dose.
Multiple myeloma and bone metastases of solid tumors: The recommended dose of Zoledronic Acid in patients with multiple myeloma and metastatic bone lesions from solid tumors is 4 mg infused every 3-4 weeks. Patients should also be administered an oral calcium supplement of 500 mg and 400 IU of Vitamin-D daily.
Interaction
In clinical studies, Acidron has been administered concomitantly with commonly used anticancer agents, diuretics, antibiotics and analgesics without interactions. Caution is advised when Acidron are administered with aminoglycosides, since these agents may have an additive effect to lower serum calcium level for prolonged periods. In multiple myeloma patients, the risk of renal dysfunction may be increased when Acidron is used in combination with thalidomide. Concomitant use of loop diuretics with Acidron increases the risk of hypocalcemia. Caution is indicated when Acidron is used with other potentially nephrotoxic drugs.
Contraindications
The drug is contraindicated if patients have hypersensitivity to the active substance or to any of the excipients or to any bisphosphonates; severe renal impairment (Creatinine clearance <30 ml/min); pregnancy and lactation.
Side Effects
The post-dose side-effects are headache, nausea, anorexia, fatigue, osteonecrosis of jaw, anemia, bone pain, constipation, fever, vomiting, flu-like syndrome, hypocalcemia, myalgia, arthralgia and hypophosphataemia.
Pregnancy & Lactation
Zoledronic acid is contraindicated during pregnancy and in breast-feeding women. It is also not recommended for use in children and adolescents below 18 years of age.
Precautions & Warnings
Patients must be appropriately hydrated prior to administration of Acidron. This is especially important in the elderly and for patients receiving diuretic therapy. Adequate hydration can be achieved by the patient drinking two glasses of fluid (such as water) before and after the infusion. Serum levels of calcium, phosphate, magnesium and potassium, as well as serum creatinine should be carefully monitored after initiating Acidron therapy. If hypocalcemia, hypophosphatemia or hypomagnesemia occurs, short-term supplemental therapy may be necessary. Moreover, careful renal function monitoring should be considered.
Overdose Effects
Clinical experience with acute over dosage is limited. Over dosage may cause hypocalcemia, hypophosphatemia, and hypomagnesemia. In such case, reduction in serum levels of calcium, phosphorus, and magnesium should be corrected by intravenous administration of calcium gluconate, potassium or sodium phosphate and magnesium sulfate respectively.
Storage Conditions
Store below 30° C prior to opening. Protect from moisture and light. Acidron must be kept out of the reach and sight of children.
Alternative brands of Zoledronic Acid [For hypercalcemia]
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.